News Daily News Apixaban Bests Rivaroxaban, Warfarin in Preventing VTE Recurrence and Bleeding The advantage of apixaban was consistent across a variety of subgroups and confirms earlier observations. L.A. McKeown May 16, 2025
Presentation ACC 2025 Oral Semaglutide Reduces Cardiovascular Events in People with Type 2 Diabetes with Atherosclerotic Cardiovascular and/or Chronic Kidney Disease: Primary Results From the SOUL Randomized Trial Presenter: Darren K. McGuire March 29, 2025
Presentation ACC 2025 Advance-HTN: Lorundrostat Efficacy and Safety in Patients with Uncontrolled Hypertension Presenter: Luke Laffin March 29, 2025
Presentation ACC 2025 Four-Factor Prothrombin Complex Concentrate is Superior to Frozen Plasma in Bleeding Adult Cardiac Surgery Patients with Coagulopathy—Results from a Phase 3, Randomized, Active-Control Study Presenter: Keyvan Karkouti March 29, 2025
Presentation Controversies and Advances 2025 Future Interventions for the Heart & Other Organs: “The Internet of the Human Body” Presenter: Kalyanam Shivkumar January 30, 2025
Presentation Controversies and Advances 2025 Management of Hyperaldosteronism: Just Treat Medically to Cast a Wider Net! Presenter: Richard J. Auchus January 30, 2025
News Conference News ESOC 2025 Less Intense Checks May Be OK After IV Thrombolysis for Stroke: OPTIMISTmain By Todd Neale May 28, 2025
News Conference News ESOC 2025 Even Small Amounts of Exercise May Help Older Women Avoid Stroke By Todd Neale May 22, 2025
News Conference News EuroPCR 2025 Myval Noninferior to Other THVs at 1 Year, but Questions Persist By L.A. McKeown May 21, 2025
News Conference News EuroPCR 2025 Meta-analysis Quashes Hopes for Routine Embolic Protection in TAVI By Michael O'Riordan May 21, 2025
News Conference News EuroPCR 2025 Complete Revascularization in STEMI Still Superior at 10 Years: DANAMI-3-PRIMULTI By Michael O'Riordan May 20, 2025